GHENT UNIVERSITY Karoline FONCK - International Centre for ...
GHENT UNIVERSITY Karoline FONCK - International Centre for ...
GHENT UNIVERSITY Karoline FONCK - International Centre for ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
In some parts of Africa, FSWs and their clients are considered to be the group at highest risk<br />
of HW infection and hence constitute an important population <strong>for</strong> targeted interventions.<br />
Studies among sex workers in Nairobi have shown a HIV prevalence rate of 67% and an<br />
annual HIV incidence of 47% (Plummer 1991).<br />
There is considerable evidence that both ulcerative and non-ulcerative STIs enhance HIV-1<br />
transmission and acquisition (Wasserheit 1992, Sewankambo 1997, Kreiss 1994, Moss<br />
1995, Laga 1993). STI control may there<strong>for</strong>e offer a means of reducing the spread of the<br />
AIDS epidemic. A randomized community trial in Mwanza, Tanzania demonstrated that<br />
improved management of symptomatic STIs resulted in a 40% reduction in HIV-1 incidence<br />
in the intervention arm (Grosskurth 1995). However, a randomized community trial of<br />
antibiotic prophylaxis every 10 months in Rakai, Uganda, failed to demonstrate any reduction<br />
in HIV-1 incidence, despite a significant reduction in the incidence of T. vaginalis and T.<br />
pallidum infection (Wawer 1999). It has been suggested that this discrepancy may be due to<br />
the maturity of the HIV-1 epidemic in Rakai at the time of the trial, which meant that most<br />
HIV-1 transmission was no longer driven by STIs (Hitchcock 1999). However, rates of N.<br />
gonorrhoeae, C. trachomatis and Haemophilus ducreyi were not significantly reduced by<br />
antibiotic prophylaxis, possibly due to their low frequency in the target population. In addition,<br />
the administration of antibiotic prophylaxis every 10 months may be inadequate, since it may<br />
have little effect on the natural history of STIs such as gonorrhea, which frequently resolve<br />
within weeks, even if untreated and which may quickly be re-acquired after treatment<br />
(Handsfield 1995, Costa 1985).<br />
A more feasible and logical approach in the face of a mature HIV-1 epidemic may be to<br />
target frequent antibiotic prophylaxis towards high-risk 'core' transmitter groups, such as sex<br />
workers, who are at high risk of acquiring both STIs and HIV-1 infection instead of targeting<br />
unselected populations.<br />
Hence we decided to set up a randomized trial of monthly azithromycin prophylaxis to<br />
prevent STIs and HIV-1 infection in a cohort of Kenyan sex workers from the Kibera district of<br />
Nairobi. Azithromycin, a macrolide antibiotic with a favorable side effect profile and a long<br />
tissue half-life, has demonstrated efficacy against the STI pathogens N. gonorrhoeae, C.<br />
trachomatis and H. ducreyi (Ridgway 1996).<br />
The objectives of this study were: (1) to evaluate the impact of regular routine azithromycin<br />
chemoprophylaxis on STI and HIV-1 incidence in this population; (2) to examine potential<br />
adverse effects of monthly azithromycin administration, including effects on antibiotic<br />
PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS INCLUDING HIV 81